Stories – Innovation

Eileen Bauer and Thomas Krakowiak promote occupational health

Eileen Bauer and Thomas Krakowiak promote occupational health An own prevention and fitness center for the Campus? Regular sports courses and health days on topics such as stress reduction or nutrition? And all of this is supported jointly by the institutions and companies on campus? Since 2016, there has been

DR. LEIF SCHRÖDER AND DR. STEPHAN PRITZ DEVELOP NEW MRI CONTRAST AGENT

DR. LEIF SCHRÖDER AND DR. STEPHAN PRITZ DEVELOP NEW MRI CONTRAST AGENT Magnetic resonance imaging (MRI) is a method for diagnosing diseases and monitoring the course of therapy. It produces sectional images of the human body without using harmful radiation. Typically, the water molecules

DR. ELISA KIEBACK AND DR. JEANETTE LIBERA-KÖRNER DRIVE “T-KNIFE” FORWARD

DR. ELISA KIEBACK AND DR. JEANETTE LIBERA-KÖRNER DRIVE “T-KNIFE” FORWARD T-knife is a spin-off company of the Max Delbrück Center for Molecular Medicine (MDC), founded in 2017 by Professor Thomas Blankenstein, Dr. Elisa Kieback and Holger Specht. Located on Campus Berlin-Buch, T-knife develops T-cell therapeutics that

Dr. Andreas Eckert founds and finances biotechnology and medical technology companies

Dr. Andreas Eckert founds and finances biotechnology and medical technology companies Dr. Andreas Eckert is not directly involved in research to find cures for diseases, but he has dedicated his career to the life sciences. His objective is to invest in promising companies in the early phase of their development, which he does with

Dr. Ralf Krähmer provides drugs with a protective shield for their journey through the body

Dr. Ralf Krähmer provides drugs with a protective shield for their journey through the body Dr. Ralf Krähmer never thought he would one day found a company in Berlin-Buch. Following his chemistry studies in Leipzig, Dr. Krähmer went to the U.S. for a research stay. From there he went to Switzerland and then on to Berlin, where he for the

Robert Fischer, MD and Dr. Karen Uhlmann are developing a new treatment for atrial fibrillation

Robert Fischer, MD and Dr. Karen Uhlmann are developing a new treatment for atrial fibrillation The prospect that the first clinical trials will lead to the successful treatment of patients inspires and motivates the team of OMEICOS Therapeutics GmbH. All previous data suggest that the scientists and founders have for the first time found a

News Leben

Planung unserer Region - Beteiligung noch bis 17. Januar möglich

Öffentliche Beteiligung zum „Strategischen Gesamtrahmen Hauptstadtregion Berlin-Brandenburg”

more ...

Die Bibliotheken der Stadtbibliothek Pankow bleiben weiter zu

Neubewertung der Lage am 14. Januar 2021

more ...

Schätze des Campus

Kunstwerke, Wissenschaftsgeschichte und Botanik sollen stärker ins Blickfeld rücken

more ...

Events Buch Berlin

14.09.2021, 09:00
GMP Biotech Summer School

Good Manufacturing Practice (GMP) Basic Course Biotechnology (English)

more ...

This website is supported by: